Correction: An “Awakener” Patient Suffering From Treatment-Resistant Depression Following Adjunctive Cariprazine
Konstantinos Bonotis
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsTreatment of Major Depression
This article has been corrected to disclose a financial relationship between the author, Konstantinos Bonotis, and Recordati, a pharmaceutical company which manufactures cariprazine. Konstantinos Bonotis served as an advisory board member for Recordati in December, 2022. As a result, an honorarium was awarded to the University of Thessaly's Research Committee.